This post is co-authored by Seth Orkand, co-chair of Robinson+Cole’s Government Enforcement + White-Collar Defense Team.

On August 25, 2025, the Department of Health and Human Services Office of Inspector General (OIG) issued a new report (Report) highlighting trends in remote patient monitoring (RPM) Medicare billing, recommending stronger oversight to ensure compliance in billing for RPM services. The Report builds on OIG’s September 2024 report, which also called for increased oversight for RPM billing. OIG’s new Report highlights the rapid growth of RPM: in 2024, Medicare payments for RPM services exceeded $500 million—a 31% increase from 2023—with nearly one million Medicare beneficiaries receiving RPM services.

OIG’s Findings

The use of RPM for Medicare enrollees has grown substantially and continuously since 2019, when Medicare began widely covering RPM services. In 2019, Medicare payments for RPM were just $15 million, growing to $536 million by 2024. Just between 2023 and 2024, the number of Medicare enrollees receiving RPM services increased by 27%. Approximately 4,600 medical practices routinely billed for RPM in 2024.

Finally, OIG discussed billing practices for multiple monitoring devices per enrollee. Generally, practices may only bill Medicare for one RPM device—such as a blood pressure cuff or connected weight scale—per month. But OIG found that a small number of practices were billing for two or more devices per month per enrollee. OIG suggested that this pattern may indicate double billing or billing for medically unnecessary services.

Implications and Conclusion

OIG’s Report signals that regulators may be taking a fresh look at RPM billing for Medicare enrollees. Given RPM’s meteoric growth in the past five years, it is not surprising that OIG is recommending increased scrutiny of potentially problematic billing practices. Providers should proactively review internal billing practices for RPM services and implement policies to better comply with RPM billing requirements. We will continue to monitor CMS and MAO adoption of OIG’s recommendations.

Photo of Danielle Tangorre Danielle Tangorre

Danielle H. Tangorre represents and advises a broad range of health care providers, including clinical laboratories, long-term care facilities, behavioral health providers, substance abuse providers, physician group practices and licensed healthcare providers.  Read her full rc.com bio here.

Photo of Ivy Miller Ivy Miller

Ivy Miller is a member of Robinson+Cole’s Health Law Group, providing counsel on the full spectrum of health law matters to health care organizations, including health systems, physician groups, hospitals, and other health care providers and suppliers. Ivy regularly advises clients on corporate…

Ivy Miller is a member of Robinson+Cole’s Health Law Group, providing counsel on the full spectrum of health law matters to health care organizations, including health systems, physician groups, hospitals, and other health care providers and suppliers. Ivy regularly advises clients on corporate and transactional matters, privacy and security issues, and federal and state health care fraud and abuse compliance, helping them navigate a complex and ever-evolving legal and regulatory environment. Read her full rc.com bio here.